219 related articles for article (PubMed ID: 2014490)
1. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.
Grainger J; Woodman K; Pearce N; Crane J; Burgess C; Keane A; Beasley R
Thorax; 1991 Feb; 46(2):105-11. PubMed ID: 2014490
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
Pearce N; Grainger J; Atkinson M; Crane J; Burgess C; Culling C; Windom H; Beasley R
Thorax; 1990 Mar; 45(3):170-5. PubMed ID: 2330548
[TBL] [Abstract][Full Text] [Related]
3. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.
Crane J; Pearce N; Flatt A; Burgess C; Jackson R; Kwong T; Ball M; Beasley R
Lancet; 1989 Apr; 1(8644):917-22. PubMed ID: 2565417
[TBL] [Abstract][Full Text] [Related]
4. Confounding by severity does not explain the association between fenoterol and asthma death.
Beasley R; Burgess C; Pearce N; Woodman K; Crane J
Clin Exp Allergy; 1994 Jul; 24(7):660-8. PubMed ID: 7953948
[TBL] [Abstract][Full Text] [Related]
5. Prescribed drug therapy and near-fatal asthma attacks.
Burgess C; Pearce N; Thiruchelvam R; Wilkinson R; Linaker C; Woodman K; Crane J; Beasley R
Eur Respir J; 1994 Mar; 7(3):498-503. PubMed ID: 8013608
[TBL] [Abstract][Full Text] [Related]
6. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
Garrett JE; Lanes SF; Kolbe J; Rea HH
Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of salmeterol and near-fatal attacks of asthma.
Williams C; Crossland L; Finnerty J; Crane J; Holgate S; Pearce N; Beasley R
Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
[TBL] [Abstract][Full Text] [Related]
8. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study.
Woodman K; Pearce N; Beasley R; Burgess C; Crane J
Clin Pharmacol Ther; 1992 May; 51(5):566-71. PubMed ID: 1587070
[TBL] [Abstract][Full Text] [Related]
9. End of the New Zealand asthma mortality epidemic.
Pearce N; Beasley R; Crane J; Burgess C; Jackson R
Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709
[TBL] [Abstract][Full Text] [Related]
10. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
Suissa S; Ernst P
J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
[TBL] [Abstract][Full Text] [Related]
11. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
Lanes SF; Birmann B; Raiford D; Walker AM
J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
[TBL] [Abstract][Full Text] [Related]
12. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.
Suissa S; Ernst P; Boivin JF; Horwitz RI; Habbick B; Cockroft D; Blais L; McNutt M; Buist AS; Spitzer WO
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):604-10. PubMed ID: 8118625
[TBL] [Abstract][Full Text] [Related]
13. Fenoterol and asthma mortality in New Zealand.
Pearce N; Crane J; Burgess C; Grainger J; Beasley R
N Z Med J; 1990 Feb; 103(884):73-5. PubMed ID: 2308729
[No Abstract] [Full Text] [Related]
14. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma.
Crane J; Pearce N; Burgess C; Woodman K; Robson B; Beasley R
Int J Epidemiol; 1992 Aug; 21(4):737-44. PubMed ID: 1521979
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
Spitzer WO; Buist AS
Thorax; 1990 Aug; 45(8):645-6. PubMed ID: 2402734
[No Abstract] [Full Text] [Related]
16. The use of beta-agonists and the risk of death and near death from asthma.
Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.
Beasley R; Pearce N; Crane J; Burgess C
Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161
[TBL] [Abstract][Full Text] [Related]
18. Confounding by indication and channeling over time: the risks of beta 2-agonists.
Blais L; Ernst P; Suissa S
Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629
[TBL] [Abstract][Full Text] [Related]
19. Fenoterol, asthma deaths, and asthma severity: confounding or confusion?
Pearce N; Burgess C; Crane J; Beasley R
Thorax; 1997 Aug; 52(8):750-1. PubMed ID: 9337841
[No Abstract] [Full Text] [Related]
20. The self-administration of inhaled beta agonist drugs during severe asthma.
Windom HH; Burgess CD; Crane J; Pearce N; Kwong T; Beasley R
N Z Med J; 1990 May; 103(889):205-7. PubMed ID: 2342689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
